Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M706628200 on November 27, 2007

J. Biol. Chem., Vol. 283, Issue 4, 2147-2155, January 25, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/4/2147    most recent
M706628200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobs, R. L.
Right arrow Articles by Vance, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobs, R. L.
Right arrow Articles by Vance, D. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Hepatic CTP:Phosphocholine Cytidylyltransferase-{alpha} Is a Critical Predictor of Plasma High Density Lipoprotein and Very Low Density Lipoprotein*

René L. Jacobs{ddagger}1, Susanne Lingrell{ddagger}, Yang Zhao{ddagger}, Gordon A. Francis§2, and Dennis E. Vance, Holder of the Canada Research Chair in Molecular and Cell Biology of Lipids and Scientist of the Alberta Heritage Foundation for Medical Research{ddagger}3

From the Canadian Institutes of Health Research Group on the Molecular and Cell Biology of Lipids and the Departments of {ddagger}Biochemistry and §Medicine, University of Alberta, Edmonton, Alberta T6G 2S2, Canada

CTP:phosphocholine cytidylyltransferase (CT) is the key regulatory enzyme in the CDP-choline pathway for the biosynthesis of phosphatidylcholine (PC). We previously generated a mouse in which the hepatic CT{alpha} gene was specifically inactivated by the cre/loxP procedure. In CT{alpha} knock-out mice, plasma high density lipoprotein (HDL) and very low density lipoprotein (VLDL) levels were markedly lower than in wild type mice (Jacobs, R. L., Devlin, C., Tabas, I., and Vance, D. E. (2004) J. Biol. Chem. 279, 47402-47410.) To investigate the mechanism(s) responsible for the decrease in plasma lipoprotein levels, we isolated primary hepatocytes from knock-out and wild type mice. ABCA1 expression was reduced in knock-out hepatocytes and apoAI-dependent cholesterol, and PC efflux was impaired. When knock-out hepatocytes were infected with an adenovirus expressing CT{alpha}, apoAI-dependent PC efflux returned partially, whereas cholesterol efflux and ABCA1 levels were not restored to normal levels. Adenoviral expression of CT{alpha} did not increase VLDL secretion in knock-out hepatocytes, even though cellular PC levels returned to normal. However, in vivo adenoviral delivery of CT{alpha} normalized plasma HDL and VLDL levels in knock-out mice. The observations demonstrate that hepatic PC biosynthesis is a key player in maintaining plasma VLDL and HDL, and further underscores the importance of the liver in HDL formation.


Received for publication, August 9, 2007 , and in revised form, November 8, 2007.

* This work was supported in part by Canadian Institutes of Health Research Grants MOP 62935 and MOP 12660. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Recipient of postdoctoral fellowships from the Canadian Institutes of Health Research and the Alberta Heritage Foundation for Medical Research.

2 Senior Scholar of the Alberta Heritage Foundation for Medical Research.

3 To whom correspondence should be addressed: 328 HMRC, University of Alberta, Edmonton, Alberta T6G 2S2, Canada. Tel.: 780-492-8286; Fax: 780-492-3383; E-mail: dennis.vance{at}ualberta.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
D. E. Vance and J. E. Vance
Physiological consequences of disruption of mammalian phospholipid biosynthetic genes
J. Lipid Res., April 1, 2009; 50(Supplement): S132 - S137.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. Gallardo, R. N. Pena, M. Amills, L. Varona, O. Ramirez, J. Reixach, I. Diaz, J. Tibau, J. Soler, J. M. Prat-Cuffi, et al.
Mapping of quantitative trait loci for cholesterol, LDL, HDL, and triglyceride serum concentrations in pigs
Physiol Genomics, November 12, 2008; 35(3): 199 - 209.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement